Advertisement

Apolipoprotein E genotype analysis in Chinese Han ethnic children with Wilson's disease, with a concentration on those homozygous for R778L

      Abstract

      Wilson's disease (WD) is an autosomal recessive disorder of copper metabolism caused by a large number of different mutations in the ATP7B gene. R778L mutation is mostly observed in Chinese, Japanese and Korean patients, whereas the H1069Q point mutation in the ATP7B gene is the most frequent mutation in European patients with WD. In our previous study we did not find a significant correlation between genotype and phenotype (age of onset and clinical presentation) in patients homozygous (37 patients) or heterozygous (52 patients) for R778L. It was reported that European patients homozygous for H1069Q who were also homozygous for the ApoE genotype ε3/3 developed clinical symptoms 5–11 years later than did patients with genotypes other than ApoE ε3/3. In the present study (i) we firstly observed that ApoE ε3/3 did not delay the onset of WD; (ii) no association between ApoE genotype and WD clinical presentation in Chinese Han children, including those patients homozygous for R778L. Thus we conclude that the onset of WD in Chinese children is not related to ApoE ε3/3, although the high frequency of ApoE ε3/3 in Chinese Han children with WD was not significantly different from that in controls.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kodama H.
        Toxicology of metals.
        in: Chang L.W. Genetic disorder of copper metabolism. Lewis Publisher, Boca Raton1996: 371-386
        • Shimizu N.
        • Suzuki M.
        • Yamaguchi Y.
        • Aoki T.
        • Matsuda I.
        • Arima M.
        A nation-wide survey for neurologic and hepato-neurologic type of Wilson disease: clinical features and hepatic copper content (in Japanese).
        No To Hattatsu (Tokyo). 1996; 28: 391-397
        • Gu Y.H.
        • Kodama H.
        • Du SL
        • Gu QJ
        • Sun H.J.
        • Ushijima H
        Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease.
        Clin Genet. 2003; 64: 479-484
        • Nanji M.S.
        • Nguyen V.T.
        • Kawasoe J.H.
        • Inui K.
        • Endo F.
        • Nakajima T.
        • et al.
        Haplotype and mutation analysis in Japanese patients with Wilson disease.
        Am J Hum Genet. 1997; 60: 1423-1429
        • Yoo H.W.
        Identification of novel mutations and the three most common mutations in the human ATP7B gene of Korean patients with Wilson disease.
        Genet Med. 2002; 4: 43S-48S
        • Thomas G.R.
        • Forbes J.R.
        • Roberts E.A.
        • Walshe J.M.
        • Cox D.W.
        The Wilson disease gene: spectrum of mutations and their consequences.
        Nat Genet. 1995; 9: 210-217
        • Shah A.B.
        • Chernov I.
        • Zhang H.T.
        • Ross B.M.
        • Das K.
        • Lutsenko S.
        • et al.
        Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype–phenotype correlation, and functional analyses.
        Am J Hum Genet. 1997; 61: 317-328
        • Schiefermeier M.
        • Kollegger H.
        • Madl C.
        • Polli C.
        • Oder W.
        • Kuhn H.
        • et al.
        The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease.
        Brain. 2000; 123: 585-590
        • Nathan B.P.
        • Bellosta S.
        • Sanan D.A.
        • Weisgraber K.H.
        • Mahley R.W.
        • Pitas R.E.
        Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro.
        Science. 1994; 264: 850-852
        • Miyata M.
        • Smith J.D.
        Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides.
        Nat Genet. 1996; 14: 55-61
        • Du S.L.
        • Len T.
        • Gu Y.H.
        • Ushijima H.
        • Kodama H.
        Long-term treatment with high-dose zinc sulphate in 36 children with Wilson's disease.
        Biomed Res Trace Elem. 2002; 13 (Tokyo): 85-88
        • Emi M.
        • Wu L.L.
        • Robertson M.A.
        • Myers R.L.
        • Hegele R.A.
        • Williams R.R.
        • et al.
        Genotyping and sequence analysis of apolipoprotein E isoforms.
        Genomics. 1988; 3: 373-379
        • Ferenci P.
        • Caca K.
        • Loudianos G.
        • Mieli-Vergani G.
        • Tanner S.
        • Sternlieb I.
        • et al.
        Diagnosis and phenotypic classification of Wilson's disease.
        Liver Int. 2003; 23: 139-142
        • Lee M.K.
        • Park A.J.
        • Nam B.Y.
        • Min K.J.
        • Kee B.S.
        • Park D.B.
        Apolipoprotein E genotype in Korean schizophrenic patients.
        J Korean Med Sci. 2001; 16: 781-783
        • Araki S.
        • Koya D.
        • Makiishi T.
        • Sugimoto T.
        • Isono M.
        • Kikkawa R.
        • et al.
        ApoE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study.
        Diabetes Care. 2003; 26: 2416-2420
        • Jin Z.Q.
        • Fan Y.S.
        • Ding J.
        • Chen M.
        • Fan W.
        • Zhang G.J.
        • et al.
        Association of apolipoprotein E 4 polymorphism with cerebral infarction in Chinese Han population.
        Acta Pharmacol Sin. 2004; 25: 352-356